Collins Mahlon A, An Jiyan, Peller Danielle, Bowser Robert
Department of Neurobiology, University of Pittsburgh, 200 South Lothrop Street, Pittsburgh, PA 15213, USA; Departments of Neurobiology and Neurology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013, USA.
Departments of Neurobiology and Neurology, St. Joseph's Hospital and Medical Center and Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013, USA.
J Neurosci Methods. 2015 Aug 15;251:72-82. doi: 10.1016/j.jneumeth.2015.05.011. Epub 2015 May 22.
Cerebrospinal fluid (CSF) has been used to identify biomarkers of neurological disease. CSF protein biomarkers identified by high-throughput methods, however, require further validation. While Western blotting (WB) is well-suited to this task, the lack of a validated loading control for CSF WB limits the method's accuracy.
We investigated the use of total protein (TP) as a CSF WB loading control. Using iodine-based reversible membrane staining, we determined the linear range and consistency of the CSF TP signal. We then spiked green fluorescent protein (GFP) into CSF to create defined sample-to-sample differences in GFP levels that were measured by WB before and after TP loading correction. Levels of CSF complement C3 and cystatin C measured by WB with TP loading correction and ELISA in amyotrophic lateral sclerosis and healthy control CSF samples were then compared.
CSF WB with the TP loading control accurately detected defined differences in GFP levels and corrected for simulated loading errors. Individual CSF sample Western blot and ELISA measurements of complement C3 and cystatin C were significantly correlated and the methods showed a comparable ability to detect between-groups differences.
CSF TP staining has a greater linear dynamic range and sample-to-sample consistency than albumin, a commonly used CSF loading control. The method accurately corrects for simulated errors in loading and improves the sensitivity of CSF WB compared to using no loading control.
The TP staining loading control improves the sensitivity and accuracy of CSF WB results.
脑脊液(CSF)已被用于识别神经疾病的生物标志物。然而,通过高通量方法鉴定的脑脊液蛋白质生物标志物需要进一步验证。虽然蛋白质印迹法(WB)非常适合这项任务,但缺乏经过验证的脑脊液WB上样对照限制了该方法的准确性。
我们研究了使用总蛋白(TP)作为脑脊液WB上样对照。通过基于碘的可逆膜染色,我们确定了脑脊液TP信号的线性范围和一致性。然后,我们将绿色荧光蛋白(GFP)加入脑脊液中,以在GFP水平上创建明确的样本间差异,在进行TP上样校正前后通过WB测量这些差异。然后比较了在肌萎缩侧索硬化症和健康对照脑脊液样本中,通过基于TP上样校正的WB和酶联免疫吸附测定(ELISA)测量的脑脊液补体C3和胱抑素C水平。
带有TP上样对照的脑脊液WB准确地检测到了GFP水平的明确差异,并校正了模拟的上样误差。脑脊液补体C3和胱抑素C的个体样本蛋白质印迹法和ELISA测量结果显著相关,并且这两种方法在检测组间差异方面具有相当的能力。
脑脊液TP染色比常用的脑脊液上样对照白蛋白具有更大的线性动态范围和样本间一致性。与不使用上样对照相比,该方法能准确校正模拟的上样误差并提高脑脊液WB的灵敏度。
TP染色上样对照提高了脑脊液WB结果的灵敏度和准确性。